Denver-based edibles manufacturer Dixie Elixirs and the inventor of MED-a-Mints cannabis-infused candy have settled a dispute over alleged trademark violations. MED-a-Mints inventor Gary Gabrel claimed that Dixie Elixirs violated the contract between them when it changed the product’s packaging, making its own name more prominent and replacing the words “cannabis infused” with “THC infused” — a move he said was dangerous because children and some adults might not realize that the mints contain pot.
In a statement, Dixie Elixirs calls a lawsuit filed by Gabrel a “disappointing public spectacle.”
The two parties “have reached an amicable separation agreement,” it says. Read more below.
While specific terms of the settlement were not disclosed, a critical component of the agreement allows that Dixie Elixirs and Edibles has the right to sell its remaining inventory of produced and packaged mints. Once the existing inventory is depleted, Dixie will no longer be required to produce the Med-a-Mints line which utilizes Bridget Marketing’s proprietary formulation.
“While today’s announcement is a bit anti-climactic in that we had never intended for this simple dissolution to be a public fight, we are are pleased that the agreement was reached in just a few short weeks following Mr. Gabrel’s disappointing public spectacle,” said Chuck Smith, COO/CFO of Dixie Elixirs.
“We wish Mr. Gabrel well, but we are of course very excited to now be free to focus on development of our own exclusive line of Dixie proprietary mints, which will follow the lead of our other award-winning edibles line in terms of quality, consistency and safety of both packaging and product.”